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Genetic evidence for selective neurotrophin 3 signalling
through TrkC but not TrkB in vivo
Anna Stenqvist1*, Karin Agerman1,2*, Fre´de´ric Marmige`re1, Liliana Minichiello3 & Patrik Ernfors1+
1Unit of Molecular Neurobiology, MBB, and 2Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm,
Sweden, and 3European Molecular Biology Laboratory, Mouse Biology Programme, Monterotondo, Italy
Neurotrophins control neuronal survival in a target-derived
manner during the period of naturally occurring cell death in
development. The specificity of this mechanism has been
attributed to a restricted spatio-temporal expression of neurotro-
phin ligands in target tissues, as well as a selective expression of
their cognate tyrosine kinase (Trk) receptors in different neuronal
subpopulations. However, several in vitro and in vivo studies of
null mutant mice have suggested that neurotrophin 3 (NT3) also
signals through the non-preferred TrkB receptor. In this study, we
have directly addressed the in vivo preference of NT3 to signal
through TrkB or TrkC, by crossing the NT3 knock-in mice
(BDNFNT3/NT3 mice) with the TrkB- or TrkC-null mutant mice.
We find that TrkB is dispensable, whereas TrkC is required for the
neuronal rescue by the NT3 allele in the brain-derived neuro-
trophic factor- and NT3-dependent cochleovestibular system. Our
results show that NT3 maintains survival of cells as well as target
innervation only through interactions with TrkC in vivo. TrkB and
TrkC receptors are thus not functionally redundant for NT3, even
when coexpressed in neurons of the cochleovestibular system.
Keywords: cochlear ganglia; inner ear; promiscuity; trophic
factors; vestibular ganglia
EMBO reports (2005) 6, 973–978. doi:10.1038/sj.embor.7400512
INTRODUCTION
Analyses of null mutant mice for neurotrophins or their receptors
suggest diverse requirements of different neurotrophins for
selective neuronal populations (Ernfors, 2001; Huang & Reichardt,
2001). The varying requirements of neurotrophins between
subpopulations of sensory neurons are set by the availability of
ligands in the target tissues, as well as a selective expression of Trk
receptors in different neurons. TrkB and TrkC messenger RNAs are
ubiquitously expressed in vestibular ganglion neurons at embryo-
nic and postnatal stages as well as in the adult (Ylikoski et al,
1993), and both brain-derived neurotrophic factor (BDNF) and
neurotrophin 3 (NT3) are present in the vestibular sensory
epithelia (Ernfors et al, 1992; Pirvola et al, 1992). Yet, ligand-
and receptor-null mutant mice show distinct and specific deficits.
In the BDNF/ mice, 80% of the vestibular ganglion neurons are
lost, accompanied by a near-complete loss of innervation of the
target sensory hair cells at birth, whereas only 56% of the neurons
are lost in the TrkB mutant mice. In the NT3/ and TrkC/ mice,
34% and 16%, respectively, of the vestibular ganglion neurons are
lost. In the cochlea, 87%, 51%, 7% and 15% of cochlear ganglion
neurons are lost in the NT3/, TrkC/, BDNF/ and TrkB/
mice, respectively (Ernfors et al, 1994, 1995; Schimmang et al,
1995). In a study by Farinas et al (1998), it was claimed that TrkB
can be directly activated by NT3 in primary neurons, both in vitro
and in vivo. Recent results using knock-in mice of BDNF and NT3
show that both BDNF and NT3 are redundant in parts of the
peripheral nervous system (Coppola et al, 2001; Agerman et al,
2003), but receptor engagement was not addressed in the latter
studies. Thus, several reports have drawn attention to the issue of
whether ligand redundancy is mirrored by a receptor redundancy.
None of the previous studies has directly addressed whether the
control of cell death and target innervation by neurotrophins is
mediated by preferred or non-preferred receptor signalling in vivo.
In this study, we have taken a genetic approach to determine
the in vivo preference of NT3 to signal through either TrkB or TrkC
in the vestibular and auditory systems. For this purpose, we used
our previously established mice, in which the coding part of the
BDNF gene has been replaced by the NT3 gene. In these mice,
NT3 can partly and completely rescue neuronal numbers in the
vestibular and cochlear systems, respectively, but only a few of the
remaining neurons still innervate the sensory epithelia (Agerman
et al, 2003). This is consistent with the fact that fibre growth
(Tessarollo et al, 2004), short-range innervation and synapto-
genesis (Agerman et al, 2003) are largely mediated by BDNF in
the inner ear. By crossing the BDNFNT3/NT3 mice with the TrkB-
or TrkC-null mutant mice, we separately eliminated each of the
two potential signalling pathways of NT3. We have focused our
analysis on the cochleovestibular system, as both TrkB and TrkC
mRNAs are expressed ubiquitously by the cochlear and vestibular
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neurons. Therefore, non-promiscuous receptor signalling can
directly be identified as such, without being confounded by the
restricted presence of receptors in different neuronal subpopula-
tions. Analysis of the BDNF-dependent cochleovestibular system
in the two mouse strains, BDNFNT3/NT3 TrkB/ and
BDNFNT3/NT3 TrkC/, shows exclusive signalling of NT3
through the TrkC receptor.
RESULTS
TrkB and TrkC expression in BDNFNT3/NT3 mice
As any discrepancies in neuronal survival between neurotrophin-
and cognate receptor-null mutant mice could be caused by
changes in receptor expression as a consequence of eliminating
the ligands, we first investigated whether genetically removing
BDNF as well as introducing the NT3 allele in place of BDNF
affected TrkB and TrkC mRNA expression. Real-time PCR showed
that, in the wild-type mice, only the full-length form of TrkC
(TrkC-FL) was expressed in the inner ear (Fig 1A), as there was an
equal number of copies of extracellular domain (TrkC-all) and
TrkC-FL mRNA transcripts (Fig 1B). TrkB-FL transcripts were
present at levels similar to those of TrkC-FL in the inner ear.
However, unlike TrkC, TrkB-all expression was fivefold that of
TrkB-FL, suggesting a 4:1 ratio of truncated to full-length TrkB
receptors. Expression of full-length and truncated TrkB and TrkC
isoforms did not differ in the wild-type and BDNFNT3/NT3 mice
(Fig 1B). These results indicate that there is no misregulation
of Trk receptors that could confound interpretations of receptor
promiscuity in the present study.
Signalling of NT3 exclusively through TrkC in vivo
Quantitative data based on morphological criteria identifying
peripheral neurons obtained from cresyl violet stainings in the
vestibular ganglion correlated well with the overt changes in
ganglion size (Fig 2; Table 1).
The neuronal loss in the vestibular ganglion of BDNF/ mice
was markedly rescued by the NT3/NT3 alleles in the BDNF locus
(22% versus 56% neurons remaining). The rescue of neuronal
numbers in the BDNFNT3/NT3 mice was not affected by eliminating
signalling through the TrkB receptor, as was seen after introducing
a null mutation of the TrkB allele (56% remaining). In contrast, the
BDNFNT3/NT3 TrkC/ mice showed a complete loss of mature
vestibular ganglion neurons (Table 1). In the cochlear ganglion,
75% of the neurons remained in the BDNF/ mice and 99% in
the BDNFNT3/NT3 mice (Agerman et al, 2003). Similar to vestibular
neurons, the rescue of cochlear neurons by the NT3/NT3 alleles
was not affected in the BDNFNT3/NT3 TrkB/ compound mutant
mice, whereas no remaining neurons could be found in the
BDNFNT3/NT3 TrkC/ mice (Table 2).
We next used immunohistochemistry for bIII tubulin (Tuj1) to
address more directly whether there is a complete absence of
neurons in the BDNFNT3/NT3 TrkC/ mice (Fig 2F–J). The results
were similar to those obtained in the histological analysis, and the
marked loss of vestibular neurons in the BDNFNT3/NT3 TrkC/
mice (Fig 2J) was confirmed.
Early rescue in BDNFNT3/NT3 mice
Most of the naturally occurring cell death in the vestibular
ganglion takes place between embryonic day 13 (E13) and E16,
and it is also during this period in development that most of the
excessive cell death in the BDNF/ mice occurs (Ernfors et al,
1995). We examined whether the neuronal rescue in BDNFNT3/NT3
mice coincided with the period of naturally occurring cell death
by counting the number of vestibular neurons at E16 and E18.
A statistical difference was found in cell numbers between these
stages in the wild-type mice, which showed 4,6157234 neurons
at E16 (n¼ 6) and 3,8237182 neurons at E18 (n¼ 8; Po0.05).
This result shows that close to 20% of the neurons present at E16
have died at E18 in the wild-type mice, indicating that the period
of normal cell death continues until E18. Much of the neuronal
rescue in the BDNFNT3/NT3 mice had already taken place at E16
(2,019764 neurons, n¼ 6) and the number of neurons remained
unchanged between E16 and E18 in the BDNFNT3/NT3 mice (E18,
2,1437248 neurons, n¼ 4). These data show that there is a rescue
of neurons in the BDNFNT3/NT3 mice throughout the period of
naturally occurring cell death. We conclude that the neuronal
rescue in the BDNFNT3/NT3 mice coincides with the period of
excessive neuronal loss in the BDNF/ mice.
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Fig 1 | TrkB and TrkC messenger RNA expression in mice of different
genotypes. (A) Illustration of the tissue dissected for real-time PCR in (B).
(B) Quantitative real-time PCR for TrkB and TrkC measuring both
truncated and full-length TrkB or TrkC (TrkB-all and TrkC-all) or only
full-length receptors (TrkB-FL and TrkC-FL). The data are presented as
copy numbers per microgram RNA. Note that full-length TrkB and TrkC
are expressed at similar levels, that there is abundant expression of
truncated TrkB and that there are no changes in the expression of any
isoforms in the BDNFNT3/NT3 mice compared with the wild-type (WT) mice.
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Rescue of innervation is dependent on TrkC signalling
Previous results illustrate that BDNF is the most important trophic
factor for a proper terminal innervation and maturation of
functional sensory nerve endings in the vestibular organ, but that
NT3 expressed from the BDNF locus in BDNFNT3/NT3 mice is
sufficient to rescue a minor afferent innervation (Agerman et al,
2003). We studied whether the remaining nerve fibre innervation
of the BDNFNT3/NT3 mice was dependent on TrkB or TrkC
signalling. We stained for bIII tubulin, which is present in both
afferents and efferents of the inner ear (Fig 3A–E; Kim et al, 2001).
Semiquantification of the staining (Fig 3F) showed a greater loss in
the epithelial layer than in the subepithelial layer of the BDNF/
mice (Fig 3B). A distinct increase in number and thickness of nerve
fibres in the sensory epithelium was found in the BDNFNT3/NT3
mice (Fig 3C) as compared with the BDNF/ mice, and this effect
remained in the BDNFNT3/NT3 TrkB/ mice (Fig 3D), showing
that the effect of NT3 is independent of TrkB. In agreement with
this, nerve fibres were nearly completely absent in both layers in
the BDNFNT3/NT3 TrkC/ mice (Fig 3E).
A greater rescue of efferent than of afferent innervation
We next examined bIII tubulin and p75NTR double immunohisto-
chemistry at high power to compare possible differences between
efferent and afferent innervation. Afferents are known to express both
p75NTR and bIII tubulin, whereas efferents express only bIII tubulin.
Consistently, p75NTR-positive fibres in the wild-type mice also
expressed bIII tubulin, whereas there were many bIII tubulin-expressing
fibres that did not stain for p75NTR (supplementary Fig 1A online).
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Fig 2 | Histological and immunohistochemical analyses of the vestibular ganglion. (A–E) Cresyl violet staining of embryonic day 18 (E18) vestibular
ganglion in mice of indicated genotypes. The arrow in (E) indicates the location at which the ganglion is missing in the BDNFNT3/NT3TrkC/ mice.
(F–J) Immunohistochemical staining for p75NTR (red) and bIII tubulin (green) of E18 vestibular ganglion in mice of indicated genotypes.
WT, wild type; V, fifth cranial nerve; VII, seventh cranial nerve. Scale bars, 50 mm.
Selective signalling of NT3 through TrkC
A. Stenqvist et al
&2005 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 6 | NO 10 | 2005
scientificreport
975
In the subepithelial layer, efferents were abundantly present in
all genotypes except the BDNFNT3/NT3 TrkC/ mice, which
displayed a marked paucity. In contrast, the presence of afferents
reflected the number of vestibular ganglion neurons remaining in
each genotype (supplementary Fig 1A–E online). In the sensory
epithelia, the efferents were very sparse in the BDNF/ and
BDNFNT3/NT3 TrkC/ mice, whereas many fibres were present
in the BDNFNT3/NT3 and BDNFNT3/NT3 TrkB/ mice. However,
afferent innervation of the sensory epithelial layer did not correlate
with the number of fibres present in the subepithelial layer, as
there was an absence in the BDNF/ and BDNFNT3/NT3 TrkC/
mice, and only a minor presence in the BDNFNT3/NT3 and
BDNFNT3/NT3 TrkB/ mice (supplementary Fig 1A–E online,
and summarized in Fig 4). From this, it is clear that NT3 expressed
from the BDNF locus is sufficient for afferent axonal growth and
projection to the subepithelial layer but not for significant target
innervation of hair cells in the sensory epithelia (which depends
on BDNF; Agerman et al, 2003).
DISCUSSION
By establishing the BDNFNT3/NT3TrkB/ and BDNFNT3/NT3TrkC/
mice and comparing neuronal survival and target innervation in
these mice with those in the BDNFNT3/NT3 and wild-type mice, we
have characterized the selectivity of NT3 to its cognate receptor,
TrkC, in vivo. Earlier studies (Agerman et al, 2003) had shown a
partial rescue of vestibular neuronal numbers in the BDNFNT3/NT3
mice but a failure to rescue the balance defect, presumably a
result of the failure of rescued neurons to innervate the hair cells.
The present results indicate that NT3 activation of TrkC is not
equivalent to BDNF activation of TrkB in supporting hair-cell
innervation and recovery of balance. Although trkB and trkC
Table 1 | Neuronal cell counts in vestibular ganglion
Mean number
of neurons7s.e.m.
Percentage of
control7s.e.m.
Wild type 3,8237182 (n¼ 8) 10075
BDNF/ 854764 (n¼ 4) 2272*
BDNFNT3/NT3 2,1437248 (n¼ 4) 5676* 1
BDNFNT3/NT3TrkB/ 2,1367105 (n¼ 8) 5673* 1
BDNFNT3/NT3TrkC/ 070 (n¼ 6) 070* 1zy
Cryostat sections from embryonic day 18 mice of the indicated genotypes were
prepared and stained with cresyl violet. Vestibular ganglion neurons with a clear
nucleus and nucleoli were counted in every third section. ANOVA Bonferroni’s
*Po0.001 between wild-type and mutant mice, 1Po0.001 between BDNF/ and
other mutant mice, zPo0.001 between BDNFNT3/NT3 and BDNFNT3/NT3TrkC/ and
yPo0.001 between BDNFNT3/NT3TrkB/and BDNFNT3/NT3TrkC/.
Table 2 | Neuronal cell counts in cochlear ganglion
Mean number
of neurons7s.e.m.
Percentage of
control7s.e.m.
Wild type 6,4997198 (n¼ 3) 10073
BDNF/ 4,8727270 (n¼ 3)a 7574a
BDNFNT3/NT3 6,4557351 (n¼ 3)a 9975a
BDNFNT3/NT3TrkB/ 6,4347244 (n¼ 7) 9974
BDNFNT3/NT3TrkC/ 070 (n¼ 6) 070* 1
Cryostat sections from embryonic day 18 mice of the indicated genotypes were
prepared and stained with cresyl violet. Cochlear ganglion neurons with a clear
nucleus and nucleoli were counted in every third section.
aData from Agerman et al (2003), reproduced with permission.
ANOVA Bonferroni’s *Po0.001 between wild-type and BDNFNT3/NT3TrkC/,
1Po0.001 between BDNFNT3/NT3TrkB/ and BDNFNT3/NT3TrkC/.
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Fig 3 | Rescue of innervation in BDNFNT3/NT3 mice occurs independent of TrkB. (A–E) Immunohistochemistry for bIII tubulin, which stains both
efferent and afferent innervation in the utricular maculae at embryonic day 18 (E18) of mice of indicated genotypes. (F) Semiquantification of nerve
fibres in the epithelial and subepithelial layers of the different genotypes. Note the greater loss of innervation in the epithelial layer in all knockout
animals. Data are 7s.e.m. WT, wild type. Scale bars, 50mm.
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mRNAs are ubiquitous in all neurons of the vestibular ganglion,
their presence at the protein level has not been examined. It is
possible that the partial neuronal rescue in the BDNFNT3/NT3 mice
(56% remaining), as compared with that in the BDNF/ mice, is
the result of neurons expressing both TrkB and TrkC, but
responding primarily to BDNF; hence, introducing the NT3/NT3
allele effectively rescues them. Others may express only TrkB
protein and therefore are not rescued by NT3. A final population
could contain only TrkC, and all neurons are therefore lost in the
BDNFNT3/NT3 TrkC/ mice.
The issue of whether neurotrophins signal through non-
preferred receptors in vivo was raised by the findings that the
NT3-null mutant mice in several peripheral ganglia show a more
severe neuronal loss than the TrkC receptor-null mutant mice
(Klein et al, 1994; Tessarollo et al, 1997; Ernfors, 2001; Huang &
Reichardt, 2001). For example, the NT3-null mutant mice lose
85% of the cochlear sensory neurons (Farinas et al, 1994; Ernfors
et al, 1995), whereas only a 51% loss has been reported in the
TrkC mutant mice (Schimmang et al, 1995). These initial findings
were followed up by studies addressing a putative non-preferred
receptor signalling by NT3, both in vivo (Farinas et al, 1998;
Huang et al, 1999, Coppola et al, 2001) and in vitro (Davies et al,
1995; Kuruvilla et al, 2004). The results from these studies are
consistent with biochemical studies indicating that, in addition to
TrkC, NT3 can, with lesser affinity, bind to and activate its non-
preferred receptors TrkA and TrkB in non-neuronal cell lines
(Barbacid, 1994). Although these results only indirectly address
the issue of ligand interactions with non-preferred receptors
in vivo, they are in agreement with a role for NT3 signalling
through its non-preferred receptors, which has become
generally accepted as a physiological process participating in
the development of the peripheral nervous system.
Other work has, however, pointed to a high degree of receptor
specificity in vivo, suggesting little, if any, interaction of
neurotrophins with non-preferred Trk receptors (ElShamy &
Ernfors, 1996; White et al, 1996; Ernfors, 2001). Consistently, in
more recent studies of the TrkC/ mice, the reported loss of
cochlear neurons is 70% (Tessarollo et al, 1997), thus approaching
the 85% loss in NT3-deficient mice. The high specificity of NT3
signalling through TrkC in the inner ear suggests a similar high
specificity and the lack of TrkB interactions also in other neuronal
populations in which NT3 is active. The evidence of NT3 acting
through TrkA in sympathetic neurons (Kuruvilla et al, 2004)
suggests that the remaining discrepancies in neuronal numbers of,
for instance, the sensory trigeminal and dorsal root ganglion could
be accounted for by its action through TrkA. Unlike the auditory
and vestibular systems, TrkA is also expressed in many neurons of
these ganglia. Because several of the analyses that suggested NT3
signalling through TrkB and TrkC were based on the detection of
protein or presence of mRNA at cellular resolution and could be
confounded by rapidly changing patterns of expression during
development, we have taken a genetic approach to determine
engagement of preferred versus non-preferred Trk receptors. Thus,
in this study, we have, for the first time, in vivo addressed the
promiscuity of receptor activation maintaining neuronal survival
by NT3. Our new results are in agreement with the latter studies
and show that, in the inner ear, NT3 signals exclusively through
TrkC in vivo. Our results strongly argue that there is a high degree of
specificity for NT3 receptor engagement in vivo and show that TrkB
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Fig 4 | Schematic drawing summarizing target innervation and neuronal
survival in all studied genotypes. The illustration of the vestibular sensory
epithelia (A) and vestibular ganglia (B), summarizing afferent (red) and
efferent (green) innervation of the epithelial layer (EL) and the subepithelial
layer (SEL) of the different genotypes. Density of afferent innervation in the
subepithelial layer had a direct correlation with ganglion size. Although
neurotrophin 3 (NT3) through TrkC activation rescued neurons and nerve
fibres in the sensory epithelia, hair-cell (HC) innervation and functional
recovery was minor in the BDNFNT3/NT3 mice. The efferents were reduced
when the number of afferents decreased. WT, wild type.
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and TrkC receptors are not functionally redundant, even when
coexpressed in individual neurons of the cochleovestibular system.
METHODS
Animals. In this study, we used offspring from the BDNFþ /
(Ernfors et al, 1994), BDNFþ /NT3 (Agerman et al, 2003), TrkBþ /
(Klein et al, 1993) and TrkCþ / (Klein et al, 1994) mice. The
offspring were genotyped with PCR.
Tissue preparation. For immunohistochemical analysis and neuro-
nal quantification, embryos were obtained from overnight mating and
the morning of the vaginal plug was considered as E0. Tissues from
E18 mice were immersionfixed in 4% paraformaldehyde overnight,
equilibrated in 10% sucrose followed by 30% sucrose, and frozen.
The tissue was sectioned in a cryostat at a thickness of 14mm.
Quantification of neuronal numbers. Sections were stained with
cresyl violet. Neuronal numbers were established by counting
neurons with a clear nucleus and nucleoli in every third section in
the ganglia. The total number of cells in a ganglion was calculated
as described before (Coggeshall, 1992). One-way analysis of
variance (ANOVA) followed by the Bonferroni post hoc test was
used for statistical analyses. A P-value ofo0.05 was considered to
be significant.
Immunohistochemistry. Sections were stained with mouse
anti-bIII tubulin (1:2,000; Promega, Southampton, UK), and rabbit
anti-p75NTR (1:200; Promega). Photomicrographs (Fig 3A–E;
supplementary Fig 1A–E online) were obtained on a confocal
microscope (Zeiss LSM510).
Semiquantification of innervation. Frames were captured from
anti-bIII-tubulin-immunostained sections at  20. The total area of
the utricular sensory epithelium and that of the subepithelial layer
were quantified separately, and the area covered with signal
above threshold was computed using ImageJ. Wild type was set to
1 and the other genotypes were normalized against this value.
Quantitative real-time PCR. Total RNA from the inner ears of E18
mice was extracted using the Absolutely RNATM Nanoprep kit
(Stratagene, La Jolla, CA, USA). Primers amplifying the extra-
cellular domain (all) or the intracellular tyrosine kinase domain
(FL) of either TrkB or TrkC and primers for the HPRT (positive
control) were designed in different exons to avoid amplification
of eventual DNA contamination. PCR products were verified by
sequencing and used for standard curves in the real-time PCR. The
samples were run on a Perkin-Elmer ABI Prism 5700.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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